Literature DB >> 26718103

Modern approaches to HLA-haploidentical blood or marrow transplantation.

Christopher G Kanakry, Ephraim J Fuchs, Leo Luznik.   

Abstract

Year:  2015        PMID： 26718103     DOI： 10.1038/nrclinonc.2015.234

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  31 in total

1.  A general practitioner's guide to hematopoietic stem-cell transplantation.

Authors:  A Bazinet; G Popradi
Journal:  Curr Oncol       Date:  2019-06-01       Impact factor: 3.677

2.  In vivo engineering of bone tissues with hematopoietic functions and mixed chimerism.

Authors:  Yu-Ru Shih; Heemin Kang; Vikram Rao; Yu-Jui Chiu; Seong Keun Kwon; Shyni Varghese
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-08       Impact factor: 11.205

3.  Double unrelated umbilical cord blood versus HLA-haploidentical bone marrow transplantation (BMT CTN 1101).

Authors:  Ephraim J Fuchs; Paul V O'Donnell; Mary Eapen; Brent R Logan; Joseph H Antin; Peter Dawson; Steven M Devine; Mary M Horowitz; Mitchell E Horwitz; Chatchada Karanes; Eric Leifer; John M Magenau; Joseph Patrick McGuirk; Lawrence E Morris; Andrew R Rezvani; Richard J Jones; Claudio G Brunstein
Journal:  Blood       Date:  2020-08-31       Impact factor: 22.113

4.  Bone marrow transplant with post-transplant cyclophosphamide for recessive dystrophic epidermolysis bullosa expands the related donor pool and permits tolerance of nonhaematopoietic cellular grafts.

Authors:  C L Ebens; J A McGrath; K Tamai; A Hovnanian; J E Wagner; M J Riddle; D R Keene; T E DeFor; R Tryon; M Chen; D T Woodley; K Hook; J Tolar
Journal:  Br J Dermatol       Date:  2019-06-28       Impact factor: 9.302

5.  Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in mice.

Authors:  Qingrong Huang; Shan He; Yuanyuan Tian; Yuting Gu; Pan Chen; Changhong Li; Jiefang Huang; Yongnian Liu; Hongshuang Yu; Min Jin; Shaoyan Hu; Qing Tong; Anqi Ma; Jian Jin; Elizabeth Hexner; Henry Fung; Ran Reshef; Yi Zhang; Yanyun Zhang
Journal:  Blood       Date:  2017-02-28       Impact factor: 22.113

6.  How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide.

Authors:  Shannon R McCurdy; Leo Luznik
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 7.  Natural Killer Cells for Therapy of Leukemia.

Authors:  Garnet Suck; Yeh Ching Linn; Torsten Tonn
Journal:  Transfus Med Hemother       Date:  2016-03-22       Impact factor: 3.747

8.  Assessing Early Supportive Care Needs among Son or Daughter Haploidentical Transplantation Donors.

Authors:  Nina D Wagner-Johnston; Susan M Hannum; JaAlah-Ai Heughan; Martha Abshire; Jennifer L Wolff; Kathryn Yarkony; Heather Symons; Richard J Jones; Sydney M Dy
Journal:  Biol Blood Marrow Transplant       Date:  2020-08-08       Impact factor: 5.742

9.  Alternative donors provide comparable results to matched unrelated donors in patients with acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in second complete remission: a report from the EBMT Acute Leukemia Working Party.

Authors:  Mohamad Mohty; Arnon Nagler; Eolia Brissot; Myriam Labopin; Domenico Russo; Sonja Martin; Christoph Schmid; Bertram Glass; Ron Ram; Zubeyde Nur Ozkurt; Jakob Passweg; Joan Hendrik Veelken; Donald Bunjes; Jane Apperley; Sebastian Giebel
Journal:  Bone Marrow Transplant       Date:  2020-03-17       Impact factor: 5.483

10.  How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide.

Authors:  Shannon R McCurdy; Leo Luznik
Journal:  Blood       Date:  2019-11-21       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.